Mobile Site ›

Heart Failure

Definition, diagnosis, and risk stratification




April 2013

Preview a Disease Management Strategies (DMS) Program

Clinical Use of Cardiac Biomarkers in Patients with Heart Failure

 

New biomarkers to help those with heart failure have been developed and may be helpful in guiding therapy. This program will discuss:

  • A review of these biomarkers
  • Use of natriuretic peptides in patients with heart failure
  • Potential use of cardiac troponin in patients with heart failure
  • Identification of novel markers such as ST2 and Galectin -3

To view the full program:

  • You must be a client of Mayo Medical Laboratories
  • You must create (or sign in with) a user ID for MayoMedicalLaboratories.com

Go to the full program.


Key